Shares of Ovid Therapeutics (NASDAQ: OVID) have more than doubled over the past four months, a performance the clinical-stage biotech company owes in part to a positive rating from an analyst. In March and again in June, Ladenburg Thalmann analyst Michael Higgins gave the stock a $20 price target. The biotech has a handful of potential treatments in its pipeline, the most advanced of which is OV101, which targets Angelman syndrome.
Here are five franchises who stood out, for better or for worse.
Five more alternate jurors were selected Friday following questioning from prosecution and defense lawyers, rounding out the 12 jurors and six alternates needed for the case against Trump to proceed.
Former New York Yankees left-hander Fritz Peterson died at the age of 82. He is probably best known exchanging wives with teammate Mike Kekich in the 1970s.
Boban Marjanović is a man of the people.
Bill Belichick's former boss Robert Kraft reportedly tanked his chances of getting hired as the Falcons head coach.
Jágr began his NHL career in 1990 with the Pittsburgh Penguins.
Our NBA experts make their predictions for every first-round series in the playoffs.
Fantasy baseball analyst Andy Behrens offers up a series of pickups to assist every manager, starting with a duo of Rockies ahead of a Colorado homestand.
'We'll deal with that Monday,' Dana White said about Arman Tsarukyan appearing to punch a fan during his UFC 300 walkout.
Never change, Gronk.
The new female track uniform looked noticeably skimpy at the bottom in one picture, which social media seized upon.
Leiter lasted 3 2/3 innings in his MLB debut for the Rangers.
Trump Media is advising investors on ways to prevent their shares from being loaned for a short-interest position.
Everything we know about the all-new 2024 Toyota Land Cruiser, including its price, fuel economy, hybrid power specs and more.
Jake Mintz & Jordan Shusterman give their early season assessment of all thirty MLB teams at the three week mark, as well as discuss the long-awaited debut of Texas Rangers pitcher Jack Leiter.
Iverson didn't get a life-size statue. Charles Barkley and Wilt Chamberlain didn't either.
Fred Zinkie examines two pitchers to deal while their value is trending up and a few others it's worth trying to acquire.
Recent reports point to a new Highlander EV and plug-in versions of Toyota's trucks.
The former employee was a warehouse coordinator in charge of Masters memorabilia.
Missed opportunities and crucial mistakes in fights often haunt fighters long after the moment has passed. For some fighters, those regrets can live on in their memories for years.